ABSTRACT:
The growing challenges to rapid commercialization are forcing us to act smarter and perform tasks in parallel. This requires the bench formulating chemist to understand the implications of all facets within the product development process and the effect of each action on the scale-up process. An important thing is that the process must deliver something (a product or service) to someone (or some organization) outside of the process, and what is delivered must be of value to that person or organization. That means someone, the customer or a client, will pay for the product or service delivered by the process. Simply put, we can say that a process is the definition of the tasks and the sequence of those tasks necessary to fulfill an objective, aligning with corporate values and strategy.
Unfortunately, innovation does not happen often (defined as “once in a blue moon”). An innovation does not have to be a breakthrough but can be more inclusive, delivering overall improvement that delivers better value for the consumer and differentiates the development from the competition. Innovation can vary from minor adjustments (evolutionary) to complete replacement (revolutionary).
It is not enough to just have a great idea. Innovation needs to have us focus on changing how we do business. There is a cascading disruption and downfall when a new or revolutionary idea takes hold. Almost everyone is engaged in introducing new ideas, new methods, and new devices. Some are "newer" than others, no doubt, but everyone is looking for new ways to get things done. The principles of “Innovation Continuum” are based on ‘disruptive’ competition causing competitive substitution, (e.g., internet disrupts how we play or receive information (think the US Postal Service), music, books); and thus introduction of new products changes consumer behavior and can effectively redraw market boundaries, thus causing obsolescence (“Creative Destruction”) of existing products. By implementing change through an open comprehensive process, innovation can become continuous, rather than a series of unrelated crisis-driven events.
This presentation focuses on (IC&CPDtm) as a 5-step Innovation Continuum & Continuous Product Development Life Cycle — using the five “W’s to discuss the innovation and product development process. Innovation has been basically looked at as a linear path from start to finish. “Innovation Continuum” is innovation a circular life-cycle that never stops. We need to think of a new beginning long before we are at the end of the process that is a never ending continuous life cycle, along with the consideration of obsolescence of new products long before they are introduced into the marketplace.

Eric Abrutyn is a graduate of New York University-New Paltz with a Masters in Chemistry and of C.W. Post College/Long Island University with a B.S. in Chemistry. He has almost 40 years of experience in the personal care cosmetics industry. Eric has been actively participating in the Society of Cosmetic Chemist for over 35 years, serving as Chair of Midwest and Ohio Valley chapters, Area II Director, Editor of New York Cosmetiscope, and various positions at the local and national level. He also is a memeber of the Technical Advisory Board and contributing editor for Cosmetics & Toiletries magazine, and is Chairman of the International Nomenclature Committee (INC)—part of Personal Care Products Council’s (formerly CTFA).
Besides working as Senior Principle Scientist for Kao Brands, Eric has worked for Dow Corning as a Senior Technical Service Scientist in the field of silicone chemistry, and Wickhen Products as Director of R&D in the field of antiperspirants, esterification, spray drying, free-radical polymerization, and controlled release. In 2009 he established a consulting firm – TPC2Advisor’s Ltd., Inc., utilizing his extensive and diverse experience to focus on supporting clientele in the areas (1) antiperspirant technology, application, and performance testing, (2) siloxane technology/applications and replacement products, (3) skin and hair care formulation and product performance testing, and (4) technology assessment.
He has contributed broadly in the fields of hair care research, skin care product development & underarm product development. Mr. Abrutyn: (a) holds over 15 patent; (b) is contributing editor/author for 4 book; (c) teaches courses in siloxane technology & application, and antiperspirant technology, application & and product performance; and (d) author of many technical articles, and numerous presentations in the field of antiperspirants, polymerization, controlled release and silicone applications.

ABSTRACT:

Join Don Orth, Ph.D., one of our favorite presenters – and the man who literally “wrote the book” on cosmetic microbiology – as he addresses some of the key issues facing cosmetic chemists today:
Keys to Successful Product Preservation: How to get products out the door – without problems. One of the first things to do is to make sure aqueous products are preserved adequately – a tricky issue in the era of paraben-free cosmetics.
Guidelines for Formulating Preservative-Free Products expands on successful preservation systems by showing what to do to reduce preservative requirements and how to make products without chemical preservatives. This is especially important for natural/organic products.
Steps for Dealing with the Bug in the Plant will show you how to eliminate house organisms – and the problems they cause. Living with house organisms is unacceptable, but microorganisms are programmed to survive - they have survival strategies (i.e., biofilm and efflux pumps) that enable them to resist conventional cleaning/sanitization procedures and preservative systems. You will see that ‘what doesn’t kill them only makes them stronger’, because microorganisms will adapt if we give them a chance. Probiotic Care for the Skin. Just as yogurt may exert positive effects in the digestive tract, we are now appreciating that our skin microflora may be beneficial to the health and beauty of skin. New thinking explores the benefit of products that maintain homeostasis – to prevent skin problems before they start - by colonization resistance and down-regulation of the skin immune system.

Dr. Donald S. Orth is a broad-based industrial microbiologist with over 40 years of experience in industry, government and academia. Orth Consulting, L.L.C. was established in 2008 to assist companies in the personal care industry meet their business objectives by addressing microbiological issues in product development, testing and release of finished products. Areas of specialization include cosmetic and drug microbiology, developing and testing of OTC-drugs, selecting preservative systems, designing preservative-free (self-preserving) products, rapid methods of preservative efficacy testing, stability testing, plant sanitation, quality assurance, and test method development. Dr. Orth has been an invited speaker at the US FDA and at international meetings.
Dr. Orth is an Adjunct Professor of Pharmaceutical Sciences in the College of Pharmacy, University of Cincinnati and has given classes at UCLA. He has been a member of the Society of Cosmetic Chemists since 1978, serving as California chapter chairman, meeting moderator, and chairman of several local and national committees of the Society. He is an SCC Emeritus member and a Fellow of the Society, has been a member of the American Society for Microbiology since 1966 and an Emeritus member since 2007, and has been a member of the American Association for the Advancement of Science since 1990. In 2006, Dr. Orth was the California Chapter’s Merit Award honoree for his many contributions to our members, and in 2007 he received the Society’s highest honor, the Maison G. de Navarre Medal Award, for his contributions to cosmetic science during his career.
Dr. Orth has written or co-authored many publications, book chapters and oral presentations, primarily on microbiology and skin physiology. He wrote the Handbook of Cosmetic Microbiology (1993; Marcel Dekker, Inc.) and Introduction to Cosmetic Microbiology (IFSCC Monograph No. 5; 1999; Micelle Press). He and Dr. Jon Kabara edited Preservative-Free and Self-Preserving Cosmetics and Drugs, Principles and Practice (1997; Marcel Dekker, Inc.). He and J.J. Kabara, S.P. Denyer and S.K. Tan edited Cosmetic and Drug Microbiology (2006; Informa Healthcare). His most recent book is Insights into Cosmetic Microbiology (2010; Allured Business Media).